Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:

Subscribers log in here

Related articles

Acute cystitis in children older than two years and adolescents


Cystitis is inflammation of the urinary bladder, usually caused by infection, which can occur alone or in conjunction with pyelonephritis.

Acute cystitis in the child older than two years and in the adolescent will be reviewed here. Urinary tract infection (UTI) in younger children (in whom it is difficult to distinguish cystitis from pyelonephritis on clinical grounds) is discussed separately. (See "Urinary tract infections in children: Epidemiology and risk factors" and "Urinary tract infections in infants and children older than one month: Clinical features and diagnosis" and "Urinary tract infections in infants and children older than one month: Acute management, imaging, and prognosis".)


The distinction between complicated and uncomplicated cystitis is based upon the presence or absence of anatomic or physiologic abnormality of the urinary tract (including pyelonephritis), host factors, and the antimicrobial resistance pattern of the uropathogen.

Uncomplicated cystitis — Uncomplicated cystitis is limited to the lower urinary tract and occurs in older children (older than two years) or adolescents with no underlying medical problems or anatomic or physiologic abnormalities. Most often it is caused by pathogens that are susceptible to the antimicrobial agents that are usually used to treat cystitis. (See 'Initial treatment' below.)

Complicated cystitis — Complicated cystitis is associated with upper tract disease, multiple-resistant uropathogens, or hosts with special considerations such as malignancy, diabetes, anatomic or physiologic abnormalities, or an indwelling bladder catheter. Patients who have urodynamic dysfunction, neurogenic bladder, or incomplete bladder emptying may harbor pathogens in residual urine, thereby creating a source for persistent or recurrent infection. Many complicated urinary tract infections (UTI) are hospital acquired and are related to indwelling urinary catheters. (See "Etiology and clinical features of bladder dysfunction in children" and "Evaluation and diagnosis of bladder dysfunction in children".)


Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Mar 2014. | This topic last updated: Dec 13, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
  1. Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468.
  2. Hansson S, Martinell J, Stokland E, Jodal U. The natural history of bacteriuria in childhood. Infect Dis Clin North Am 1997; 11:499.
  3. Johnson JR, Stamm WE. Diagnosis and treatment of acute urinary tract infections. Infect Dis Clin North Am 1987; 1:773.
  4. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997; 11:551.
  5. Langley JM, Hanakowski M, Leblanc JC. Unique epidemiology of nosocomial urinary tract infection in children. Am J Infect Control 2001; 29:94.
  6. Stover BH, Shulman ST, Bratcher DF, et al. Nosocomial infection rates in US children's hospitals' neonatal and pediatric intensive care units. Am J Infect Control 2001; 29:152.
  7. Siroky MB. Pathogenesis of bacteriuria and infection in the spinal cord injured patient. Am J Med 2002; 113 Suppl 1A:67S.
  8. Elliott SP, Villar R, Duncan B. Bacteriuria management and urological evaluation of patients with spina bifida and neurogenic bladder: a multicenter survey. J Urol 2005; 173:217.
  9. Schlager TA, Whittam TS, Hendley JO, et al. Comparison of expression of virulence factors by Escherichia coli causing cystitis and E. coli colonizing the periurethra of healthy girls. J Infect Dis 1995; 172:772.
  10. Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin North Am 2006; 53:379.
  11. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am J Med 2002; 113 Suppl 1A:14S.
  12. Gaspari RJ, Dickson E, Karlowsky J, Doern G. Antibiotic resistance trends in paediatric uropathogens. Int J Antimicrob Agents 2005; 26:267.
  13. Edlin RS, Shapiro DJ, Hersh AL, Copp HL. Antibiotic resistance patterns of outpatient pediatric urinary tract infections. J Urol 2013; 190:222.
  14. Cherry JD, Nadipuram S. Adenoviruses. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th, Cherry JD, Harrison GJ, Kaplan SL, et al. (Eds), Elsevier Saunders, Philadelphia 2014. p.1888.
  15. Brouwer KC, Ndhlovu PD, Wagatsuma Y, et al. Urinary tract pathology attributed to Schistosoma haematobium: does parasite genetics play a role? Am J Trop Med Hyg 2003; 68:456.
  16. Hofland CA, Eron LJ, Washecka RM. Hemorrhagic adenovirus cystitis after renal transplantation. Transplant Proc 2004; 36:3025.
  17. Ison MG. Adenovirus infections in transplant recipients. Clin Infect Dis 2006; 43:331.
  18. Boeckh M, Erard V, Zerr D, Englund J. Emerging viral infections after hematopoietic cell transplantation. Pediatr Transplant 2005; 9 Suppl 7:48.
  19. Erard V, Storer B, Corey L, et al. BK virus infection in hematopoietic stem cell transplant recipients: frequency, risk factors, and association with postengraftment hemorrhagic cystitis. Clin Infect Dis 2004; 39:1861.
  20. Kauffman CA, Vazquez JA, Sobel JD, et al. Prospective multicenter surveillance study of funguria in hospitalized patients. The National Institute for Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis 2000; 30:14.
  21. Orth RW, Weisman MH, Cohen AH, et al. Lupus cystitis: primary bladder manifestations of systemic lupus erythematosus. Ann Intern Med 1983; 98:323.
  22. Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000; 343:992.
  23. Wald ER. Cystitis and pyelonephritis. In: Feigin and Cherry’s Textbook of Pediatric Infectious Diseases, 7th, Cherry JD, Harrison GJ, Kaplan SL, et al. (Eds), Elsevier Saunders, Philadelphia 2014. p.535.
  24. Huppert JS, Biro F, Lan D, et al. Urinary symptoms in adolescent females: STI or UTI? J Adolesc Health 2007; 40:418.
  25. KASS EH. Asymptomatic infections of the urinary tract. Trans Assoc Am Physicians 1956; 69:56.
  26. Hellerstein S. Urinary tract infections. Old and new concepts. Pediatr Clin North Am 1995; 42:1433.
  27. Tran D, Muchant DG, Aronoff SC. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1279 patients. J Pediatr 2001; 139:93.
  28. Prais D, Straussberg R, Avitzur Y, et al. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 2003; 88:215.
  29. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003; 88:444.
  30. Mehr SS, Powell CV, Curtis N. Cephalosporin resistant urinary tract infections in young children. J Paediatr Child Health 2004; 40:48.
  31. Bradley JS, Jackson MA, Committee on Infectious Diseases, American Academy of Pediatrics. The use of systemic and topical fluoroquinolones. Pediatrics 2011; 128:e1034.
  32. Karlowsky JA, Jones ME, Thornsberry C, et al. Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999. Int J Antimicrob Agents 2001; 18:121.
  33. Subcommittee on Urinary Tract Infection, Steering Committee on Quality Improvement and Management, Roberts KB. Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 2011; 128:595.
  34. Michael M, Hodson EM, Craig JC, et al. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child 2002; 87:118.
  35. Keren R, Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics 2002; 109:E70.
  36. Fitzgerald A, Mori R, Lakhanpaul M, Tullus K. Antibiotics for treating lower urinary tract infection in children. Cochrane Database Syst Rev 2012; 8:CD006857.
  37. Kauffman CA. Candiduria. Clin Infect Dis 2005; 41 Suppl 6:S371.
  38. Infectious Diseases Society of America. Standards, practice guidelines, and statements developed and/or endorsed by IDSA. (Accessed on October 15, 2008).
  39. Yusuf U, Hale GA, Carr J, et al. Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients. Transplantation 2006; 81:1398.
  40. Faraci M, Cuzzubbo D, Lanino E, et al. Low dosage cidofovir without probenecid as treatment for BK virus hamorrhagic cystitis after hemopoietic stem cell transplant. Pediatr Infect Dis J 2009; 28:55.